Beacon Pharmaceuticals PLC Share Price

Equities

BEACONPHAR

BD0482BECON5

Pharmaceuticals

End-of-day quote Dhaka S.E. 03:30:00 16/07/2024 am IST 5-day change 1st Jan Change
144 BDT -2.11% Intraday chart for Beacon Pharmaceuticals PLC -8.05% -41.22%

Financials

Sales 2022 802.27Cr 6.81Cr 569.02Cr Sales 2023 850.99Cr 7.23Cr 603.57Cr Capitalization 5.66TCr 48Cr 4.01TCr
Net income 2022 94Cr 79.39L 66Cr Net income 2023 51Cr 43.3L 36Cr EV / Sales 2022 7.85 x
Net Debt 2022 328.23Cr 2.79Cr 232.8Cr Net Debt 2023 697.78Cr 5.92Cr 494.91Cr EV / Sales 2023 7.47 x
P/E ratio 2022
63.8 x
P/E ratio 2023
111 x
Employees 3,872
Yield 2022
0.62%
Yield 2023
0.65%
Free-Float 36.94%
More Fundamentals * Assessed data
Dynamic Chart
Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Beacon Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Beacon Pharmaceuticals plc Announces Appointment of Md. Sahabuddin FCS as Company Secretary CI
Beacon Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Beacon Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Beacon Pharmaceuticals plc Recommends Cash Dividend for the Year Ended June 30, 2023 CI
Beacon Pharmaceuticals plc Appoints Mr. Ulfat Karim as the Director and Chief Operating Officer CI
Beacon Pharmaceuticals PLC Announces Appointment of Jalal Uddin as Chief Financial Officer CI
Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as CFO CI
Beacon Pharmaceuticals plc Announces Resignation of Abdul Haque Sarder as Director (Finance & Accounts) CI
Beacon Pharmaceuticals PLC Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Beacon Pharmaceuticals Limited will Change its Name to Beacon Pharmaceuticals PLC CI
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Beacon Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
More news
1 day-2.11%
1 week-8.05%
Current month-6.37%
1 month-6.31%
3 months-31.62%
6 months-41.22%
Current year-41.22%
More quotes
1 week
143.00
Extreme 143
157.70
1 month
143.00
Extreme 143
169.00
Current year
133.60
Extreme 133.6
288.90
1 year
133.60
Extreme 133.6
288.90
3 years
133.60
Extreme 133.6
393.00
5 years
20.00
Extreme 20
393.00
10 years
11.90
Extreme 11.9
393.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 67 12/01/12
Director of Finance/CFO - -
Chief Administrative Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 67 12/01/12
Chairman 65 -
Director/Board Member 40 -
More insiders
Date Price Change Volume
16/24/16 144 -2.11% 95,087
15/24/15 147.1 -0.54% 69,096
14/24/14 147.9 -2.31% 89,144
11/24/11 151.4 -2.45% 69,970
10/24/10 155.2 -0.89% 127,489

End-of-day quote Dhaka S.E., July 16, 2024

More quotes
Beacon Pharmaceuticals PLC, formerly Beacon Pharmaceuticals Limited, is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing and marketing of pharmaceutical finished formulation products and lifesaving Intravenous (I.V) fluids, active pharmaceuticals ingredients, biotech products and genetic engineering products which it sells in the local markets as well as the international markets. The Company also provides contract manufacturing and tool manufacturing services. Its products are focused on various drugs, such as anticancer, cardiovascular, gastrointestinal, antibiotics, anti-coagulants, protein supplements, muscle relaxant, antihistamine, analgesics, and non-steroidal anti-inflammatory drugs (NSAIDS), among others. The Company's product categories include general, oncology, anti-viral and biotech. Its products include Favipiravir, Remdisivir INN, Meropenem, Bendamustine, Bleomycin Sulfate, Daunorubicin, Gemcitabine, Darbepoetin alfa and Filgrastim.
More about the company
  1. Stock Market
  2. Equities
  3. BEACONPHAR Stock